Compounds > sr141716
Page last updated: 2024-08-26

sr141716 and Action Tremor

sr141716 has been researched along with Action Tremor in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's1 (20.00)24.3611
2020's2 (40.00)2.80

Authors

AuthorsStudies
Bergman, J; Iliopoulos-Tsoutsouvas, C; Makriyannis, A; Nikas, SP; Papanastasiou, I; Paronis, C1
Fantegrossi, WE; Hiranita, T; Wilson, CD1
Armentero, MT; Baqi, Y; Bonaventura, J; Canela, EI; Casadó, V; Cortés, A; Costa, G; Farré, D; Franco, R; Lanciego, JL; Lluís, C; Mallol, J; Martínez-Pinilla, E; McCormick, P; Müller, CE; Pinna, A; Sánchez, M; Simola, N1
Cowan, A; Huang, P; Liu-Chen, LY; Unterwald, EM1
Baker, D; Brown, P; Croxford, JL; Huffman, JW; Layward, L; Pertwee, RG; Pryce, G1

Other Studies

5 other study(ies) available for sr141716 and Action Tremor

ArticleYear
Evidence for spontaneous cannabinoid withdrawal in mice.
    Behavioural pharmacology, 2022, 04-01, Volume: 33, Issue:2&3

    Topics: Animals; Cannabinoids; Dronabinol; Mice; Piperidines; Pyrazoles; Rimonabant; Tremor

2022
Cannabimimetic effects of abused indazole-carboxamide synthetic cannabinoid receptor agonists AB-PINACA, 5F-AB-PINACA and 5F-ADB-PINACA in mice: Tolerance, dependence and withdrawal.
    Drug and alcohol dependence, 2022, 07-01, Volume: 236

    Topics: Amides; Animals; Cannabinoid Receptor Agonists; Cannabinoids; Humans; Hypothermia; Indazoles; Male; Mice; Receptor, Cannabinoid, CB1; Rimonabant; Substance-Related Disorders; Tremor; Valine

2022
L-DOPA disrupts adenosine A(2A)-cannabinoid CB(1)-dopamine D(2) receptor heteromer cross-talk in the striatum of hemiparkinsonian rats: biochemical and behavioral studies.
    Experimental neurology, 2014, Volume: 253

    Topics: Adenosine A2 Receptor Antagonists; Animals; Antiparkinson Agents; Cannabinoid Receptor Antagonists; Cholinesterase Inhibitors; Corpus Striatum; Disease Models, Animal; Dopamine Agents; Dose-Response Relationship, Drug; Drug Interactions; Functional Laterality; Levodopa; Male; Oxidopamine; Parkinsonian Disorders; Piperidines; Protein Binding; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor Cross-Talk; Rimonabant; Tacrine; Time Factors; Tremor

2014
Hyperlocomotion and paw tremors are two highly quantifiable signs of SR141716-precipitated withdrawal from delta9-tetrahydrocannabinol in C57BL/6 mice.
    Neuroscience letters, 2009, Nov-06, Volume: 465, Issue:1

    Topics: Analysis of Variance; Animals; Dronabinol; Dyskinesia, Drug-Induced; Forelimb; Locomotion; Male; Mice; Mice, Inbred C57BL; Motor Activity; Piperidines; Psychotropic Drugs; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Substance Withdrawal Syndrome; Tremor

2009
Cannabinoids control spasticity and tremor in a multiple sclerosis model.
    Nature, 2000, Mar-02, Volume: 404, Issue:6773

    Topics: Animals; Camphanes; Cannabinoids; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Mice; Multiple Sclerosis; Piperidines; Pyrazoles; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Spasm; Tremor

2000